GYR-777 series (Biota)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGYR-777 series (Biota)
Drug Alias Nametopoisomerase IV inhibitors (Biota)DNA gyrase inhibitors (Biota)ATPase/DNA gyrase/DNA topoisomerase IV inhibitor (Prolysis)GYR-777
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA gyrase degradersATPase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyraseATPase
Therapy Area/IndicationsSkin Diseases, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProlysis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiota Holdings LtdProlysis LtdVaxart Inc
Active IndicationsN/A
Inactive IndicationsSkin Diseases, Bacterial

Other Information

ATC CodeN/A
Related LinksN/A